Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
30.69
+0.97 (3.26%)
At close: Oct 23, 2026, 4:00 PM EDT
30.63
-0.06 (-0.20%)
After-hours: Oct 23, 2026, 7:42 PM EDT

Alamar Biosciences Revenue

Alamar Biosciences had revenue of $29.43M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $100.42M. In the year 2025, Alamar Biosciences had annual revenue of $74.21M with 195.17% growth. That makes Alamar Biosciences the 22,596th largest company in the world by revenue and 3,286th in the United States.

Revenue (ttm)
$100.42M
Revenue Growth
+195.17%
P/S Ratio
21.21
Revenue / Employee
$351,119
Employees
286
Market Cap
2.13B

Revenue Chart

Revenue by Geography

  • United States 45.42M 61.2%
  • Europe, Middle East and Africa (Excluding Germany) 14.12M 19.0%
  • Germany 8.31M 11.2%
  • Asia-Pacific 5.82M 7.8%
  • Rest of The World 539.00K 0.7%
Fiscal year ended Dec 31, 2025 See the full Alamar Biosciences breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202574.21M49.07M195.17%
Dec 31, 202425.14M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.